Literature DB >> 32656314

COVID-19-A theory of autoimmunity to ACE-2.

Philip McMillan1, Bruce D Uhal2.   

Abstract

Entities:  

Year:  2020        PMID： 32656314      PMCID： PMC7351250     

Source DB:  PubMed          Journal:  MOJ Immunol        ISSN： 2373-4442


× No keyword cloud information.
  35 in total

1.  Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.

Authors:  Bruce D Uhal; Xiaopeng Li; Anita Xue; Xu Gao; Amal Abdul-Hafez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-10       Impact factor: 5.464

Review 2.  The role of ACE2 in cardiovascular physiology.

Authors:  Gavin Y Oudit; Michael A Crackower; Peter H Backx; Josef M Penninger
Journal:  Trends Cardiovasc Med       Date:  2003-04       Impact factor: 6.677

3.  Lung injury induced by antibody fragments to angiotensin-converting enzyme.

Authors:  P R Caldwell; H J Wigger; L T Fernandez; R M D'Alisa; D Tse-Eng; V P Butler; I Gigli
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

4.  Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system.

Authors:  Slava Epelman; W H Wilson Tang; Stephen Y Chen; Frederick Van Lente; Gary S Francis; Subha Sen
Journal:  J Am Coll Cardiol       Date:  2008-08-26       Impact factor: 24.094

Review 5.  ACE2, a promising therapeutic target for pulmonary hypertension.

Authors:  Vinayak Shenoy; Yanfei Qi; Michael J Katovich; Mohan K Raizada
Journal:  Curr Opin Pharmacol       Date:  2011-01-05       Impact factor: 5.547

6.  Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases.

Authors:  Yuko Takahashi; Shiori Haga; Yukihito Ishizaka; Akio Mimori
Journal:  Arthritis Res Ther       Date:  2010-05-14       Impact factor: 5.156

7.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

8.  SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells.

Authors:  Soeren Lukassen; Robert Lorenz Chua; Timo Trefzer; Nicolas C Kahn; Marc A Schneider; Michael Kreuter; Christian Conrad; Roland Eils; Thomas Muley; Hauke Winter; Michael Meister; Carmen Veith; Agnes W Boots; Bianca P Hennig
Journal:  EMBO J       Date:  2020-04-14       Impact factor: 11.598

9.  Transmission potential and severity of COVID-19 in South Korea.

Authors:  Eunha Shim; Amna Tariq; Wongyeong Choi; Yiseul Lee; Gerardo Chowell
Journal:  Int J Infect Dis       Date:  2020-03-18       Impact factor: 3.623

10.  Neurologic Features in Severe SARS-CoV-2 Infection.

Authors:  Julie Helms; Stéphane Kremer; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Christine Kummerlen; Olivier Collange; Clotilde Boulay; Samira Fafi-Kremer; Mickaël Ohana; Mathieu Anheim; Ferhat Meziani
Journal:  N Engl J Med       Date:  2020-04-15       Impact factor: 91.245
View more
  11 in total

1.  Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research.

Authors:  Amal Abdul-Hafez; Tarek Mohamed; Bruce D Uhal
Journal:  J Lung Pulm Respir Res       Date:  2021-05-03

Review 2.  Immunogenetic Association Underlying Severe COVID-19.

Authors:  Kendall McCoy; Autumn Peterson; Yun Tian; Yongming Sang
Journal:  Vaccines (Basel)       Date:  2020-11-20

3.  Upregulation of the Renin-Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients.

Authors:  Loris Zamai
Journal:  Cells       Date:  2021-02-27       Impact factor: 6.600

Review 4.  COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

Authors:  Larissa E van Eijk; Mathijs Binkhorst; Arno R Bourgonje; Annette K Offringa; Douwe J Mulder; Eelke M Bos; Nikola Kolundzic; Amaal E Abdulle; Peter Hj van der Voort; Marcel Gm Olde Rikkert; Johannes G van der Hoeven; Wilfred Fa den Dunnen; Jan-Luuk Hillebrands; Harry van Goor
Journal:  J Pathol       Date:  2021-03-25       Impact factor: 9.883

Review 5.  COVID-19-A Theory of Autoimmunity Against ACE-2 Explained.

Authors:  Philip McMillan; Thomas Dexhiemer; Richard R Neubig; Bruce D Uhal
Journal:  Front Immunol       Date:  2021-03-23       Impact factor: 7.561

6.  Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.

Authors:  Sk Sarif Hassan; Shinjini Ghosh; Diksha Attrish; Pabitra Pal Choudhury; Alaa A A Aljabali; Bruce D Uhal; Kenneth Lundstrom; Nima Rezaei; Vladimir N Uversky; Murat Seyran; Damiano Pizzol; Parise Adadi; Antonio Soares; Tarek Mohamed Abd El-Aziz; Ramesh Kandimalla; Murtaza M Tambuwala; Gajendra Kumar Azad; Samendra P Sherchan; Wagner Baetas-da-Cruz; Kazuo Takayama; Ángel Serrano-Aroca; Gaurav Chauhan; Giorgio Palu; Adam M Brufsky
Journal:  Molecules       Date:  2020-12-13       Impact factor: 4.411

Review 7.  Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection.

Authors:  Catherine Chen; Aisah Amelia; George W Ashdown; Ivo Mueller; Anna K Coussens; Emily M Eriksson
Journal:  Mol Med       Date:  2021-12-20       Impact factor: 6.354

Review 8.  Pathophysiology of COVID-19-associated acute kidney injury.

Authors:  Matthieu Legrand; Samira Bell; Lui Forni; Michael Joannidis; Jay L Koyner; Kathleen Liu; Vincenzo Cantaluppi
Journal:  Nat Rev Nephrol       Date:  2021-07-05       Impact factor: 42.439

Review 9.  Does COVID-19 Vaccination Warrant the Classical Principle "ofelein i mi vlaptin"?

Authors:  Michael Doulberis; Apostolis Papaefthymiou; Georgios Kotronis; Dimitra Gialamprinou; Elpidoforos S Soteriades; Anthony Kyriakopoulos; Eleftherios Chatzimichael; Kyriaki Kafafyllidou; Christos Liatsos; Ioannis Chatzistefanou; Paul Anagnostis; Vitalii Semenin; Smaragda Ntona; Ioanna Gkolia; Dimitrios David Papazoglou; Nikolaos Tsinonis; Spyros Papamichos; Hristos Kirbas; Petros Zikos; Dionisios Niafas; Jannis Kountouras
Journal:  Medicina (Kaunas)       Date:  2021-03-09       Impact factor: 2.430

10.  Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT).

Authors:  Benjamin Meyer; Johan Reimerink; Giulia Torriani; Fion Brouwer; Gert-Jan Godeke; Sabine Yerly; Marieke Hoogerwerf; Nicolas Vuilleumier; Laurent Kaiser; Isabella Eckerle; Chantal Reusken
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.